StonvexLoading…
StonvexCore line items from STKE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 |
|---|---|---|
Revenue | C$14.56M | C$10.67M |
Operating Income | C$-44.81M | C$8.19M |
Net Income | C$-35.04M | C$6.61M |
EPS (Diluted) | C$-1.74 | C$0.35 |
Total Assets | C$169.60M | C$28.90M |
Total Liabilities | C$54.82M | C$2.18M |
Cash & Equivalents | C$1.79M | C$1.81M |
Free Cash Flow OCF − CapEx | C$-11.03M | Not available |
Shares Outstanding | 23.00M | 18.27M |